[Examination and treatment of dyslipemia after myocardial infarction--are the goals achieved?].
According to guidelines, medical treatment of dyslipidaemia in post-AMI patients should await assessment of underlying lipid disorders and the outcome of dietary treatment. The risk of patients not being treated with lipid-lowering therapy because of lack of follow-up has led to more aggressive guidelines recommending statin treatment even before discharge from hospital. In a study comprising 730 patients, we have shown that, although most patients were discharged from the coronary care unit without statin treatment, a traditional rehabilitation programme succeeded in assessing more than 95% of the patients for underlying lipid disorders, and more than 75% of patients with plasma cholesterol > or = 5.5 mmol/l received lipid-lowering therapy within the first year. Most patients were treated with statins. Statins, however, were given in smaller doses than those used in the clinical trials, and only 52% of the treated patients reached the recommended goal of plasma cholesterol lower than 5 mmol/l.
Kanstrup
H
H
Arhus Universitetshospital, Arhus Amtssygehus, medicinsk-kardiologisk afdeling og klinisk biokemisk afdeling. helle.kanstrup@aas.auh.dk
Lassen
J F
JF
Heickendorff
L
L
Larsen
M L
ML
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control* / Q000534:rehabilitation; D010351:Patient Discharge; D017410:Practice Guidelines as Topic
D000960:Hypolipidemic Agents; D002784:Cholesterol
Udredning og behandling af dyslipidaemi efter akut myokardieinfarkt--opnås målene?